These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14869377)

  • 1. A coagulation defect due to an anticoagulant possessing antithromboplastic and antithrombic properties, probably heparin.
    BELL WN
    Blood; 1951 Nov; 6(11):1199-1203. PubMed ID: 14869377
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemorrhagic diathesis associated with hyperheparinemia.
    SPEER RJ; HILL JM; MALONEY M; ROBERTS A
    J Lab Clin Med; 1955 May; 45(5):730-9. PubMed ID: 14368040
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation defects in obstetric shock: meconium embolism and heparin; fibrin embolism and defibrination.
    SCHNEIDER CL
    Am J Obstet Gynecol; 1955 Apr; 69(4):758-75. PubMed ID: 14361493
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemorrhagic diathesis caused by heparinoid type of circulating anticoagulants].
    JIMENEZ CASADO M
    Rev Clin Esp; 1956 Apr; 61(2):107-9. PubMed ID: 13350763
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of hemorrhagic diathesis due to a circulating anticoagulant].
    POST CR; DEN OTTOLANDER GJ; HOORWEG PG
    Ned Tijdschr Geneeskd; 1956 Jun; 100(24):1703-9. PubMed ID: 13348734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Congenital hereditary coagulation disorder caused by a heparin-like antibody].
    HENI F; KRAUS I
    Klin Wochenschr; 1956 Jul; 34(27-28):747-9. PubMed ID: 13347053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apropos of a case of hemorrhagic diathesis caused by circulating anticoagulant. Importance of thromboelastography for the diagnosis].
    ROUSSEL-LE GUEN JC; DURAFFOURD P
    Rev Fr Gynecol Obstet; 1961 Apr; 56():317-29. PubMed ID: 13744012
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of hemostasis and blood coagulation in the course of uremia. Role of a heparinoid anticoagulant].
    MORIAU M; MASURE R
    J Urol Nephrol (Paris); 1962; 68():163-9. PubMed ID: 14476046
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemorrhagic diathesis due to a circulating anticoagulant. Report of case with laboratory observations.
    PONS ER; DE TORREGROSA MV
    Blood; 1952 Jan; 7(1):20-30. PubMed ID: 14886406
    [No Abstract]   [Full Text] [Related]  

  • 10. BLEEDING DISORDERS.
    ERSLEV AJ
    Med Sci; 1964 Jun; 15():78-89. PubMed ID: 14158727
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of haemorrhagic diathesis due to a circulating anticoagulant.
    POST CR; DEN OTTOLANDER GJ; HOORWEG PG
    Acta Haematol; 1957 Oct; 18(4):290-6. PubMed ID: 13487182
    [No Abstract]   [Full Text] [Related]  

  • 12. [SOME BASIC PROBLEMS OF ANTICOAGULANT THERAPY].
    RAEK K
    Orv Hetil; 1964 Jul; 105():1345-52. PubMed ID: 14184213
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemorrhagic diathesis associated with long-term anticoagulant therapy.
    BOYLES PW
    South Med J; 1960 Apr; 53():441-6. PubMed ID: 13803598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorrhagic diathesis in cirrhosis of the liver].
    Tytgat GN; Collen DJ; De Vreker RA
    Nouv Rev Fr Hematol; 1968; 8(1):123-30. PubMed ID: 4232756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Predisposition for bleeding and coagulation disorders in uremia].
    GROSS R; NIETH H; MAMMEN E
    Klin Wochenschr; 1958 Feb; 36(3):107-12. PubMed ID: 13540129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circulating anticoagulant of antithromboplastic activity].
    ALAGILLE D; CROSNIER J; SOULIER JP
    Rev Fr Etud Clin Biol; 1956 Mar; 1(3):335-45. PubMed ID: 13351012
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consumption coagulopathy as the cause of hemorrhagic diathesis in acute acetic acid intoxication].
    Paar D; Heimsoth V; Werner M; Bock KD
    Dtsch Med Wochenschr; 1968 Feb; 93(5):206-9. PubMed ID: 5639652
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
    BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.